logo

For the Inventor, By the Inventor

Berlin, Germany

Schering Aktiengesellschaft


USPTO Granted Patents = 1,409

% Expired Patents = 12.1



Trademarks = 11

Forward Citations = 16,280

Loading Chart...
Loading Chart...

1,246 inventors (with patents filed for the assignee):

goldMedal Rudolf Wiechert (125 out of 144 patents)

silverMedal Walter Elger (99 out of 122 patents)

bronzeMedal Werner Skuballa (95 out of 106 patents)

4.  Henry Laurent (88 out of 88 patents)

5.  Johannes Platzek (85 out of 128 patents)

6.  Hanns-Joachim Weinmann (63 out of 67 patents)

7.  Heinz Gries (63 out of 67 patents)

8.  Gerhard Sauer (58 out of 58 patents)

9.  Friedrich Arndt (58 out of 59 patents)

10.  Andreas Huth (55 out of 66 patents)

11.  Gunter Neef (50 out of 51 patents)

12.  Ulrich Niedballa (49 out of 52 patents)

13.  Helmut Hofmeister (49 out of 49 patents)

14.  Bernd Raduchel (47 out of 47 patents)

15.  Helmut Vorbruggen (46 out of 49 patents)


Core Competencies:
Pharmaceutical Agents
Anti-Inflammatory
Fluorescent Contrast
CDK Inhibitors
Sulfonamide Compounds
Prostaglandin Derivatives
Pyrimidines
Hormone-Dependent Diseases
Radiohalogenated Compounds
Inhibitory Agents
Benzamide Derivatives
Steroid Crystals

1,409 patents:

1. 7563924 - 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments (2009-07-21),
2. 7528173 - Plasma carboxypeptidase B inhibitors (2009-05-05),
3. RE40703 - Cell differentiation inducer, benzamide compounds (2009-04-27),
4. 7511059 - Thiazolidinones, their production and use as pharmaceutical agents (2009-03-31),
5. 7507725 - Compounds with sulphonamide group and pharmaceutical compositions containing these compounds (2009-03-24),
6. 7504410 - Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents (2009-03-17),
7. 7488468 - Near infrared fluorescent contrast agent and fluorescence imaging (2009-02-10),
8. 7482498 - Device and process for nucleophilic fluorination (2009-01-27),
9. 7481993 - Chelators for radioactively labeled conjugates comprising a stabilizing sidechain (2009-01-27),
10. 7473415 - Near infrared fluorescent contrast agent and method for fluorescence imaging (2009-01-06),
11. 7468470 - Medicinal patch that leaves less adhesive residue when removed (2008-12-23),
12. 7462718 - Process for the production of high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate (2008-12-09),
13. 7459470 - N-oxide anthranylamide derivatives and their use as medicaments (2008-12-02),
14. 7456191 - N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents (2008-11-25),
15. 7442794 - Rearranged pentanols, a process for their production and their use as anti-inflammatory agents (2008-10-28),
Company Overview
Schering Aktiengesellschaft, headquartered in Berlin, Germany, is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of innovative pharmaceutical compounds. The company focuses on a range of therapeutic areas, including anti-inflammatory agents and treatments for hormone-dependent diseases. Schering is recognized for its expertise in various core technologies, such as CDK inhibitors, sulfonamide compounds, and prostaglandin derivatives, contributing significantly to advancements in medical science.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

1,409 Patents

#1 in D-1000 Berlin

#35 in Germany

#707 in the World

Berlin, DE
Berlin, Germany

Schering Aktiengesellschaft

Forward Citations = 16,280

1,246 inventors:

goldMedal Rudolf Wiechert (125 out of 144 patents)

silverMedal Walter Elger (99 out of 122 patents)

bronzeMedal Werner Skuballa (95 out of 106 patents)

4.  Henry Laurent (88 out of 88 patents)

5.  Johannes Platzek (85 out of 128 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Schering Aktiengesellschaft. Retrieved from https://idiyas.com/company/schering-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…